Afon Technology, a Chepstow, South Wales-based med-tech startup, raised £600K in funding.
The backers were not disclosed.
The company intends to use the funds to accelerate growth and expand operations.
Led by CEO Sabih Chaudhry, Afon Technology develops a non-invasive, wearable blood glucose meter. The compact device is designed to be worn with a watchstrap and connected via Bluetooth to the user’s smart watch/device.The technology is patented and has undergone extensive clinical testing at a diabetes testing clinic in Germany and further testing at an NHS site in the UK. It has been designed to address both the diabetes and wearables markets, complying all major global regulatory requirements.
FinSMEs
22/11/2022